Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 4, 2015, Pages 988-997.e6

  Wehr, Claudia ^a   Gennery, Andrew R ^b   Lindemans, Caroline ^c   Schulz, Ansgar ^d   Hoenig, Manfred ^d   Marks, Reinhard ^a   Recher, Mike ^e   Gruhn, Bernd ^f   Holbro, Andreas ^e   Heijnen, Ingmar ^e   Meyer, Deborah ^g   Grigoleit, Goetz ^h   Einsele, Hermann ^h   Baumann, Ulrich ⁱ   Witte, Thorsten ⁱ   Sykora, Karl Walter ⁱ   Goldacker, Sigune ^a   Regairaz, Lorena ^j   Aksoylar, Serap ^k   Ardeniz, Ömur ^l   Zecca, Marco ^m   Zdziarski, Przemyslaw ⁿ   Meyts, Isabelle ^o   Matthes Martin, Susanne ^p   Imai, Kohsuke ^q   Kamae, Chikako ^r   Fielding, Adele ^s   Seneviratne, Suranjith ^t   Mahlaoui, Nizar ^u   Slatter, Mary A ^v   Güngör, Tayfun ^g   Arkwright, Peter D ^w   Van Montfrans, Joris ^c   Sullivan, Kathleen E ^x   Grimbacher, Bodo ^a   Cant, Andrew ^b   Peter, Hans Hartmut ^a   Finke, Juergen ^a   Gaspar, H Bobby ^y   Warnatz, Klaus ^a   Rizzi, Marta ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f JENA UNIVERSITY HOSPITAL   (Germany)

^g UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^h University Hospital Basel ^*  (Germany)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j Hospital de Ninos Sor Maria Ludovica   (Argentina)

^k EGE UNIVERSITY   (Turkey)

^l EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^m FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁿ Lower Silesian Centre for Cellular Transplantation   (Poland)

^o UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^p MEDICAL UNIVERSITY OF VIENNA   (Austria)

^q TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^r NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t Dept Liver Transplant H   (United Kingdom)

^u HÔPITAL NECKER ENFANTS MALADES   (France)

^v NEWCASTLE UNIVERSITY   (United Kingdom)

^w UNIVERSITY OF MANCHESTER   (United Kingdom)

^x CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^y UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Common variable immunodeficiency; hematopoietic stem cell transplantation; hypogammaglobulinemia; immunoglobulin substitution replacement; immunologic reconstitution; mortality; outcome; survival

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CHIMERA; COMMON VARIABLE IMMUNODEFICIENCY; COMORBIDITY; DISEASE COURSE; FEMALE; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NATURAL KILLER CELL; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REMISSION; SURVIVAL RATE; ADOLESCENT; ADVERSE EFFECTS; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926258207     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.11.029     Document Type: Article

References (44)

1. W. Al-Herz, A. Bousfiha, J.L. Casanova, T. Chatila, M.E. Conley, and C. Cunningham-Rundles Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency Front Immunol 5 2014 162
2. C. Wehr, T. Kivioja, C. Schmitt, B. Ferry, T. Witte, and E. Eren The EUROclass trial: defining subgroups in common variable immunodeficiency Blood 111 2008 77 85
3. B. Piqueras, C. Lavenu-Bombled, L. Galicier, F. Bergeron-van der Cruyssen, L. Mouthon, and S. Chevret Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects J Clin Immunol 23 2003 385 400
4. A. Giovannetti, M. Pierdominici, F. Mazzetta, M. Marziali, C. Renzi, and A.M. Mileo Unravelling the complexity of t cell abnormalities in common variable immunodeficiency J Immunol 178 2007 3932 3943
5. D. Moratto, A.V. Gulino, S. Fontana, L. Mori, S. Pirovano, and A. Soresina Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients Clin Immunol 121 2006 203 214
6. G.J. Driessen, M.C. van Zelm, P.M. van Hagen, N.G. Hartwig, M. Trip, and A. Warris B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency Blood 118 2011 6814 6823
7. C. Kamae, N. Nakagawa, H. Sato, K. Honma, N. Mitsuiki, and O. Ohara Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles J Allergy Clin Immunol 131 2013 1437 1440.e5
8. H. Chapel, M. Lucas, M. Lee, J. Bjorkander, D. Webster, and B. Grimbacher Common variable immunodeficiency disorders: division into distinct clinical phenotypes Blood 112 2008 277 286
9. H. Chapel, M. Lucas, S. Patel, M. Lee, C. Cunningham-Rundles, and E. Resnick Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts J Allergy Clin Immunol 130 2012 1197 1198.e9
10. G. Mouillot, M. Carmagnat, L. Gérard, J.L. Garnier, C. Fieschi, and N. Vince B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease J Clin Immunol 30 2010 746 755
11. H. Chapel, and C. Cunningham-Rundles Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions Br J Haematol 145 2009 709 727
12. I. Quinti, C. Agostini, S. Tabolli, G. Brunetti, F. Cinetto, and A. Pecoraro Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency Blood 120 2012 1953 1954
13. E.S. Resnick, E.L. Moshier, J.H. Godbold, and C. Cunningham-Rundles Morbidity and mortality in common variable immune deficiency over 4 decades Blood 119 2012 1650 1657
14. M.L.G. Ochtrop, S. Goldacker, A.M. May, M. Rizzi, R. Draeger, and D. Hauschke T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency Blood 118 2011 309 318
15. M. Perreau, S. Vigano, F. Bellanger, C. Pellaton, G. Buss, and D. Comte Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders J Exp Med 211 2014 2033 2045
16. M. Malphettes, L. Gérard, M. Carmagnat, G. Mouillot, N. Vince, and D. Boutboul Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect Clin Infect Dis 49 2009 1329 1338
17. A.R. Gennery, M.A. Slatter, L. Grandin, P. Taupin, A.J. Cant, and P. Veys Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 126 2010 602 610.e11
18. M. Rizzi, C. Neumann, A.K. Fielding, R. Marks, S. Goldacker, and J. Thaventhiran Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency J Allergy Clin Immunol 128 2011 1371 1374.e2
19. C.M. Roifman, R. Somech, F. Kavadas, L. Pires, A. Nahum, and I. Dalal Defining combined immunodeficiency J Allergy Clin Immunol 130 2012 177 183
20. M.L. Sorror, M.B. Maris, B. Storer, B.M. Sandmaier, R. Diaconescu, and C. Flowers Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities Blood 104 2004 961 968
21. M. Sorror, B. Storer, B.M. Sandmaier, D.G. Maloney, T.R. Chauncey, and A. Langston Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation Cancer 112 2008 1992 2001
22. M.L. Sorror Comorbidities and hematopoietic cell transplantation outcomes Hematology 2010 2010 237 247
23. M.L. Sorror How I assess comorbidities before hematopoietic cell transplantation Blood 121 2013 2854 2863
24. J.R. Passweg, I. Walker, K.A. Sobocinski, J.P. Klein, M.M. Horowitz, and S.A. Giralt Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants Br J Haematol 125 2004 613 620
25. D. Przepiorka, D. Weisdorf, P. Martin, H.G. Klingemann, P. Beatty, and J. Hows 1994 Consensus Conference on Acute GVHD Grading Bone Marrow Transplant 15 1995 825 828
26. A.H. Filipovich, D. Weisdorf, S. Pavletic, G. Socie, J.R. Wingard, and S.J. Lee National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report Biol Blood Marrow Transplant 11 2005 945 956
27. L.M. Ball, and R.M. Egeler Acute GvHD: pathogenesis and classification Bone Marrow Transplant 41 Suppl 2008 S58 S64
28. A.A. Hussein, C.M. Halkes, G. Socié, A. Tichelli, P.A. von dem Borne, and M.N.P.M. Schaap Outcome of allogeneic stem cell transplantation for patients transformed to myelodysplastic syndrome or leukemia from severe aplastic anemia: a report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Biol Blood Marrow Transplant 20 2014 1448 1450
29. C. Dufour, M. Pillon, J. Passweg, G. Socié, A. Bacigalupo, and G. Franceschetto Outcome of aplastic anemia in adolescence. A survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Haematologica 99 2014 1574 1581
30. F. Peinemann, and A.M. Labeit Stem cell transplantation of matched sibling donors compared with immunosuppressive therapy for acquired severe aplastic anaemia: a Cochrane systematic review BMJ Open 4 2014 e005039
31. A.R. Gennery, K. Khawaja, P. Veys, R.G. Bredius, L.D. Notarangelo, and E. Mazzolari Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002 Blood 103 2004 1152 1157
32. E. Holler, H.J. Kolb, A. Möller, J. Kempeni, S. Liesenfeld, and H. Pechumer Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 75 1990 1011 1016
33. R. Schots, L. Kaufman, I. Van Riet, T. Ben Othman, M. De Waele, and B. Van Camp Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation Leukemia 17 2003 1150 1156
34. T. Ueland, S.S. Frøland, J. Bollerslev, and P. Aukrust Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency Eur J Clin Invest 31 2001 72 78
35. P. Aukrust, E. Lien, A.K. Kristoffersen, F. Müller, C.J. Haug, and T. Espevik Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences Blood 87 1996 674 681
36. S. Gregersen, T.M. Aaløkken, G. Mynarek, B. Fevang, A.M. Holm, and T. Ueland Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors Ann Allergy Asthma Immunol 104 2010 503 510
37. W.I. Bensinger, P.J. Martin, B. Storer, R. Clift, S.J. Forman, and R. Negrin Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers N Engl J Med 344 2001 175 181
38. M. Cavazzana-Calvo, I. André-Schmutz, L. Dal Cortivo, B. Neven, S. Hacein-Bey-Abina, and A. Fischer Immune reconstitution after haematopoietic stem cell transplantation: obstacles and anticipated progress Curr Opin Immunol 21 2009 544 548
39. M. Geddes, and J. Storek Immune reconstitution following hematopoietic stem-cell transplantation Best Pract Res Clin Haematol 20 2007 329 348
40. M.A. Avanzini, F. Locatelli, C. Dos Santos, R. Maccario, E. Lenta, and M. Oliveri B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells Exp Hematol 33 2005 480 486
41. A.D. Petropoulou, R. Porcher, R.P. de Latour, A. Xhaard, D. Weisdorf, and P. Ribaud Increased infection rate after preemptive rituximab treatment for Epstein-Barr Virus reactivation after allogeneic hematopoietic stem-cell transplantation Transplant J 94 2012 879 883
42. S. Glauzy, J. Soret, I. Fournier, C. Douay, H. Moins-Teisserenc, and R. Peffault de Latour Impact of acute and chronic graft-vs-host disease on human B-cell generation and replication Blood 124 2014 2459 2462
43. A. Isgrò, M. Marziali, I. Mezzaroma, G. Luzi, A.M. Mazzone, and V. Guazzi Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency J Immunol 174 2005 5074 5081
44. W.M. Comans-Bitter, R. de Groot, R. van den Beemd, H.J. Neijens, W.C. Hop, and K. Groeneveld Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations J Pediatr 130 1997 388 393